Two GLP-1 medications, semaglutide and – to a lesser extent – liraglutide, were shown to be effective in reducing the risk of worsening mental illness in people who also have diabetes, a large Swedish study has found.
This site is intended for health professionals only
Two GLP-1 medications, semaglutide and – to a lesser extent – liraglutide, were shown to be effective in reducing the risk of worsening mental illness in people who also have diabetes, a large Swedish study has found.
Join our community today and enjoy free, unlimited access to all content. It’s quick, easy, and completely free.
Nursing in Practice delivers a daily dose of incisive news, features, opinions, clinical advice and CPD curated specifically for nurses working in general practice and community settings.
RegisterIf you are not a healthcare professional and would like access to Nursing in Practice content, please contact [email protected].